- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
REXULTI - 2mg - 28
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N05AX16 | B | Brexpiprazole - 2mg | 10433 | 75720/1 | REXULTI | 2mg | 28 | Tablet, film coated | Oral | Sadco | H. Lundbeck A/S under license from Otsuka Pharmaceutical Co., Ltd, Japan | Denmark | 13,433,051 L.L | 21.26 | C | H. Lundbeck AS | Denmark | 2/5/2024 | 0 |